SCHEMBL7397402

SCHEMBL7397402

Nc1cccc(OCCN2CCC(Cc3ccccc3)CC2)c1

nearest known ligand 0.76

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 2/20 0.76
SIGMAR1 Q99720 2/20 0.76
SLC6A4 P31645 2/20 0.62
SLC6A2 P23975 1/20 0.62
MAOB P27338 4/20 0.59
ACHE P22303 2/20 0.57
PRMT3 O60678 1/20 0.56
CARM1 Q86X55 1/20 0.56
PRMT6 Q96LA8 1/20 0.56
PRMT1 Q99873 1/20 0.56
PRMT8 Q9NR22 1/20 0.56
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
LTA4H P09960 1/20 0.54
HTR1A P08908 1/20 0.54
CCR3 P51677 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888854 0.87 TMEM97 (1.00) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL6302956 0.86 TMEM97 (0.82) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL7402809 0.86 HRH3 (0.57) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL7402049 0.85 TMEM97 (0.72) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL7403890 0.85 TMEM97 (0.76) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL7402782 0.85 TMEM97 (0.76) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
Bromide SCHEMBL7410089 0.85 TMEM97 (0.80) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
Hydrochloric Acid SCHEMBL7407310 0.84 TMEM97 (0.74) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL7403499 0.83 TMEM97 (0.73) TMEM97SIGMAR1SLC6A4SLC6A2MAOB
SCHEMBL7401219 0.83 TMEM97 (0.68) TMEM97SIGMAR1SLC6A4SLC6A2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed